Novo Nordisk A/S

CPSE-NOVO B

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						122,021	126,946	140,800	176,954	232,261	258,003
Total Revenues % Chg.						9.1%	4%	10.9%	25.7%	31.3%	28.2%
Cost of Goods Sold, Total						20,088	20,932	23,658	28,448	35,765	39,917
Gross Profit						101,933	106,014	117,142	148,506	196,496	218,086
Selling General & Admin Expenses, Total						35,830	36,886	41,058	50,684	61,598	63,205
R&D Expenses						14,220	15,462	17,199	23,287	31,029	36,246
Other Operating Expenses						-600	-460	-332	-1,034	-119	62
Other Operating Expenses, Total						49,450	51,888	57,925	72,937	92,508	99,513
Operating Income						52,483	54,126	59,217	75,569	103,988	118,573
Interest Expense, Total						-220	-390	-289	-378	-542	-542
Interest And Investment Income						65	337	231	239	1,069	1,069
Net Interest Expenses						-155	-53	-58	-139	527	527
Income (Loss) On Equity Invest.	—					-137	149	-24	-189	81	81
Currency Exchange Gains (Loss)						-3,212	-747	344	-4,651	1,652	1,058
Other Non Operating Income (Expenses)						-281	-150	-122	-181	-197	-229
EBT, Excl. Unusual Items						48,698	53,325	59,357	70,409	106,051	120,010
Gain (Loss) On Sale Of Investments						-145	-195	296	-587	37	37
Gain (Loss) On Sale Of Assets	—		—	—	—	—	—	—	—	—	—
Asset Writedown	—	—	—	—	—	—	—	-573	-760	-1,414	-7,114
Other Unusual Items	—		—	—	—	—	—	—	—	—	—
EBT, Incl. Unusual Items						48,553	53,130	59,080	69,062	104,674	112,933
Income Tax Expense						9,602	10,992	11,323	13,537	20,991	23,035
Earnings From Continuing Operations						38,951	42,138	47,757	55,525	83,683	89,898
Net Income						38,951	42,138	47,757	55,525	83,683	89,898
Net Income to Common Incl Extra Items						38,951	42,138	47,757	55,525	83,683	89,898
Net Income to Common Excl. Extra Items						38,951	42,138	47,757	55,525	83,683	89,898
Total Shares Outstanding						4,704	4,625	4,557.8	4,500.7	4,458.3	4,457.7
Weighted Avg. Shares Outstanding						4,748.6	4,667.8	4,593.2	4,530.6	4,482.8	4,463.5
Weighted Avg. Shares Outstanding Dil						4,757.4	4,680	4,606.2	4,544.6	4,494.8	4,477
EPS						8.2	9	10.4	12.3	18.7	20.1
EPS Diluted						8.2	9	10.4	12.2	18.6	20.1
EBITDA						56,310	58,565	63,770	80,875	109,813	126,561
Effective Tax Rate						19.8%	20.7%	19.2%	19.6%	20.1%	20.4%